How to deal with resistance to Sotorasib

Currently, the specific treatment options for Sotorasib (Sotorasib) resistance are still under continuous research and discussion, so some information may be supplemented or updated in future studies. Drug resistance is a complex phenomenon involving multiple factors, including tumor genetic variation, mutation diversity, and treatment strategies.

1.Gene mutation analysis: First of all, detailed gene mutation analysis is crucial for patients who develop drug resistance. Understanding what mutations have occurred in cancer cells and whether new mutations have emerged is the key to formulating subsequent treatment strategies. This analysis is usually performed through methods such as genetic sequencing to obtain detailed genetic information about the tumor.

2.Combination therapy: Based on confirmation of drug resistance, one strategy is to consider using different anticancer drugs for combination therapy. Other targeted drugs, chemotherapy drugs, or immunotherapy may be used to increase the pressure on cancer cells, block different survival pathways, and improve the therapeutic effect.

3.Participation in clinical trials: Patients may consider participating in relevant clinical trials, especially those testing novel treatments or combination drug strategies. Clinical trials provide an opportunity to try out new treatment options within the framework of scientific research, while also contributing to medical research.

4.Regular monitoring: For patients, regular monitoring is the key. Surveillance includes clinical examination, imaging examination, laboratory examination, etc., as well as attention to symptoms. With regular monitoring, doctors can detect any signs of disease progression or recurrence earlier and adjust treatment plans.

5.Individualized treatment: When considering drug resistance, treatment plans should be more individualized. Understanding the patient's overall health, other potential comorbidities, drug allergies, and other factors can help determine the best treatment path.

6.Comprehensive treatment strategy: Sometimes, a comprehensive treatment strategy may be an effective option, that is, combining multiple treatments, including surgery, radiotherapy, targeted therapy, etc. This combination of treatments aims to attack cancer on multiple levels, improving the overall effectiveness of treatment.

7.Supportive treatment: At the same time as treatment, it is also very important to provide good supportive care. This includes measures to relieve symptoms, improve quality of life, and nutritional support.

It needs to be emphasized that drug resistance varies greatly among individuals, and the best treatment strategy needs to be formulated by a professional medical team based on the patient's specific situation. Drug resistance is not only a challenge, but also a continuous effort in medical research to find more effective treatment strategies and improve patients' survival rate and quality of life. During any treatment, close collaboration and communication with the medical team is key to ensuring optimal outcomes.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.